This showed that the tumor volumes were increased in the cisplatin-treated mice injected with PANC-1 cells and CBS-knockdown CAFs, compared with cisplatin-treated mice injected with CBS-control CAFs (Figure 7D). The gene discussed is TBX1; the disease is neoplasm.